Andrew Chan Talks Transformative Medicines Nov. 17
Post Date: October 31, 2025 | Publish Date:
The senior vice president at Genentech, Inc., presents “50 Years of Monoclonal Antibody Technology: Past, Present and Future”
Envisioning Our Future For Children: Andrew Chan, MD, PhD
Nov. 17, 2025, noon EST
Zoom
Join us as biotechnology leader Andrew Chan, MD, PhD, brings his extensive experience in antibody-based therapies and immune-disease research to the Envisioning Our Future for Children lecture series at Cincinnati Children’s.
Chan oversees multidisciplinary research at Genentech that spans oncology, immunology, ophthalmology, neuroscience and infectious disease — pioneering innovations that translate into therapies for patients. His career as an immunologist and rheumatologist is defined by his deep investigations into how the immune system protects the body and how dysfunction leads to disease. Notably, his work on B-cell biology helped bring to fruition ocrelizumab (Ocrevus™), the first B-cell-directed therapy approved for both relapsing and progressive multiple sclerosis. He has published over 100 scientific papers, multiple reviews and books, and was named a Distinguished Fellow of the American Association of Immunologists in 2025.
Chan also fosters meaningful collaboration across academia, industry and advocacy. He serves as chair of the National Council at Washington University School of Medicine, chair of the Executive Advisory Board of the Chemistry-Life-Processes Institute at Northwestern University and chair of the Scientific Advisory Board of the Lupus Research Alliance.
He earned his bachelor’s and master’s degrees in chemistry from Northwestern University, his MD and PhD from Washington University in St. Louis, completed residency at Barnes Hospital and fellowship at University of California San Francisco, where he continues as an adjunct associate professor of Medicine.
Register to attend the virtual presentation.
Mark your calendar for the next speaker in the series:
Chris Karp
Director, Global Health Discovery & Translational Sciences, Gates Foundation
Nov. 24, 2025, 4 pm
Zoom
Don’t Miss a Post:
- Subscribe to the Research Horizons Newsletter
- Follow Cincinnati Children’s Research Foundation on Bluesky, X and LinkedIn
Latest Posts
About this blog
The Research Horizons blog features news and insights about the latest discoveries and innovations developed by the scientists of Cincinnati Children's. This blog does not provide medical advice, diagnosis, or treatment. Email researchnews@cchmc.org with questions or ideas.
Subscribe to Our Newsletter